Debilitating and persistent, diabetes mellitus (DM) is a serious health issue. The World Health Organization found that between 1980 and 2014, the global prevalence of diabetes increased from 108 million to 422 million. According to the Centers for Disease Control and Prevention (CDC), 11.3% of Americans, or about 37.3 million people, have diabetes. Comorbidities, such as hypertension, dyslipidemia, and obesity, that are common among diabetic patients contribute to the higher risk of death and disability from cardiovascular diseases (CVD). In addition to cognitive impairment in older people as a result of neurodegeneration (ND), diabetes has been found to be the most prevalent chronic condition that affects these individuals. It is interesting to note that the prevalence of cognitive disability and dementia as well as the prevalence of diabetes both increase with increasing age. In addition, cognitive disability and dementia are more likely to occur when cardiovascular disease (CVD) and other related risk factors are present. Therefore, diabetes, cardiovascular illnesses, and neurodegeneration are all intertwined with one another in a complex way.

My research objective is to identify novel drugs or repurpose existing drugs to improve the overall quality of life of patients with diabetes, cardiovascular, and neurodegenerative disease. My lifelong aspiration is to contribute to the enhancement of public health through my research activities, which may include wet or dry laboratory experiments in either academia or research centers.